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Cytochrome P450 monooxygenases (P450s), which represent the major group of drug metabolizing enzymes in humans, also catalyze important
synthetic and detoxicative reactions in insects, plants and many microbes. Flexibilities in their catalytic sites and membrane associations are thought to
play central roles in substrate binding and catalytic specificity. To date, Escherichia coli expression strategies for structural analysis of eukaryotic
membrane-bound P450s by X-ray crystallography have necessitated full or partial removal of their N-terminal signal anchor domain and, often,
replacement of residues more peripherally associated with the membrane (such as the F-G loop region). Even with these modifications, investigations of
P450 structural flexibility remain challenging with multiple single crystal conditions needed to identify spatial variations between substrate-free and
different substrate-bound forms. To overcome these limitations, we have developed methods for the efficient expression of 13C- and 15N-labeled P450s
and analysis of their structures by magic-angle spinning solid-state NMR (SSNMR) spectroscopy. In the presence of co-expressed GroEL and GroES
chaperones, full-length (53 kDa) Arabidopsis 13C,15N-labeled His4CYP98A3 is expressed at yields of 2–4 mg per liter of minimal media without the
necessity of generating side chain modifications or N-terminal deletions. Precipitated His4CYP98A3 generates high quality SSNMR spectra consistent
with a homogeneous, folded protein. These data highlight the potential of these methodologies to contribute to the structural analysis of membrane-
bound proteins.
© 2007 Elsevier B.V. All rights reserved.Keywords: Cytochrome P450 monooxygenases (P450s); Heterologous expression; Membrane protein; Solid-state NMR analysis1. Introduction
Cytochrome P450 monooxygenases (P450s) are ubiquitous
and extensively reiterated in the genomes of higher organismswith
humans containing 55 full-length genes, mosquitoes (Anopheles
gambiae) containing 100 genes and plants (Arabidopsis thaliana,
Oryza sativa) containing 245 and 334 genes, respectively,⁎ Corresponding author. Department of Cell and Developmental Biology,
University of Illinois at Urbana-Champaign, 1201 W. Gregory Dr., 161 Edward
R. Madigan Laboratory (ERML), Urbana, IL 61801, USA. Tel.: +1 217 333
8784; fax: +1 217 244 1336.
E-mail address: maryschu@uiuc.edu (M.A. Schuler).
0005-2736/$ - see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2007.09.009[http://drnelson.utmem.edu/CytochromeP450.html; http://p450.
antibes.inra.fr; http://Arabidopsis-P450.biotec.uiuc.edu and
Refs. [1–4]]. Mediating a range of hydroxylations, epoxida-
tions, heteroatom dealkylations and aryl migrations, human
P450s are best known for their roles in drug metabolism and
steroid biosynthesis [5], insect P450s are known for mediating
the detoxification of plant toxins and insecticides [6,7] and
those in microorganisms are known for antibiotic syntheses and
hydrocarbon hydroxylations [8]. Plant P450s mediate the
detoxification of many environmentally damaging compounds,
including herbicides, insecticides and pollutants, as well as the
synthesis of defense compounds, including flavonoids, phenyl-
propanoids and terpenes, that protect them from their many
predators and invasive pathogens [9–12].
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aromatic hydroxylations in the A. thaliana phenylpropanoid
pathway leading to lignin, flavonoids and anthocyanins [13].
Although these P450s metabolize similar substrates, they
are extremely substrate-specific with Arabidopsis CYP98A3
mediating the 3-hydroxylation of p-coumaroylshikimic acid
and p-coumaroylquinic acid but not p-coumaraldehyde [14]
and Triticum aestivum (wheat) CYP98A12 mediating these
same hydroxylations as well as that of p-coumaroyltyramine
[15]. Homology modeling and site-directed mutagenesis in
CYP98A3 have revealed topological details important for
substrate–protein interactions [Ref. [16] and S. Rupasinghe and
M.A. Schuler, unpublished]. But, more detailed annotations of
this protein's interactions with its substrates require structural
analyses using physical methodologies (e.g., X-ray crystallog-
raphy, NMR spectroscopy).
At present, 27 unique P450 structures are available in the
NCBI Molecular Modeling Database (MMDB, http://www.
ncbi.nlm.nih.gov/Structure/) or the Brookhaven Protein Data-
base (PDB, http://www.rcsb.org). Comparisons between these
structures indicate that the P450 fold is unique and the overall
fold is quite conservative with a predominant α-helical α-
domain that harbors the heme and a smaller β-sheet β-domain
that contains the N-terminal anchor found in endoplasmic
reticulum (ER)-localized eukaryotic P450s [17,18]. The ability
of some P450s, such as human CYP2D6 and CYP3A4, to
metabolize multiple substrates [5] and the varying structures of
human CYP2C9 bound to warfarin [19] and CYP3A4 bound to
small (metyrapone and progesterone) versus large substrates
(ketoconazole and erythromycin) [20,21] indicate that P450s are
structurally flexible [22,23]. Studies with rabbit CYP2B4 and
Sulfolobus solfataricus CYP119 have shown that the F- and
G-helices and their intervening loop are flexible enough to
undergo open-and-close motions upon substrate binding
[24,25]. Crystallographic experiments with Mycobacterium
tuberculosis CYP51 with and without various substrates
document flexibility in the region of the B'- and C-helices and
their intervening loop as well as in the I-helix that are important
for the induced fit binding of substrates [26,27].
The phospholipid component of the membrane has also been
shown to affect catalysis and electron transfer between P450 and
its reductase partner. Atomic force microscopy studies have
shown the P450 protein sits upright on the lipid bilayer with its
proximal and distal surfaces perpendicular to the lipid surface
and regions close to the signal anchor domain dipped in the
bilayer [28,29]. In addition to this membrane anchor domain,
regions close to substrate access channel pw1a (designated as in
Wade et al. [30]) and the F–G loop region appear to be embedded
in the membrane.
High-level expression of these eukaryotic microsomal P450s
in E. coli for crystallization studies has required deletion of the
transmembrane signal anchor domain (SAD) from each of these
proteins and, sometimes, substitution of hydrophobic residues in
the F–G loop that associates with the lipid bilayer [31]. Because
of this, investigations of P450 structural flexibilities by X-ray
crystallography have remained challenging with many condi-
tions needing to be tested for production of well-diffractingsingle crystals. In contrast to X-ray structure determinations,
solid-state NMR spectroscopy (SSNMR) does not require single
crystals to obtain high-resolution data. Several SSNMR studies
over the past decade have demonstrated that if a protein is
properly folded, hydrated and has microscopic order, high
spectroscopic resolution with well-optimized instruments is at-
tainable over a wide range of sample conditions [32–37].
Consequently, NMR analysis is capable of assessing interactions
between macromolecules and their ligands, defining structural
details of membrane-embedded proteins [38], monitoring
molecular dynamics over a large range of time scales and
studying the structures of weakly populated protein states that
may play important roles in function [39]. Furthermore, NMR
data can potentially be incorporated into homology modeling
algorithms to refine computer models without completely rely-
ing on theoretical assessment tools.
Despite these advantages, the problems encountered in
expressing membrane proteins in E. coli for structural studies
are compounded by the requirement that proteins for NMR
analysis be labeled in minimal media with one or more isotopes
(13C, 15N, 2H) derived from glucose, ammonium chloride and/or
deuterium oxide [40]. While many soluble proteins have been
effectively expressed under these stressed growth conditions,
only short truncated fragments of one P450 (the N-terminal SAD
and F–G loop of prostaglandin synthase) have been expressed in
isotopic labeling media [41,42]. In this paper, we have adapted
the protocols of Marley et al. [40] for expression of isotopically
labeled His4CYP98A3. Biochemical analysis of this protein
indicates that it is structurally intact and suitable for SSNMR
analysis. The initial SSNMR spectra reveal the high sensitivity
of this preparation and display narrow (b0.5 ppm) line widths.
The number of signals observed is consistent with a single
backbone conformation at most sites throughout the protein.
These data demonstrate the ability of SSNMR to elucidate
structural and mechanistic information of CYP98A3. In cases
such as CYP98A3, when crystal structures are not yet available,
SSNMR provides an impetus for improving molecular models
and identifying key structural features that affect substrate
specificity and membrane interactions. In other CYP monoox-
ygenases where crystal structures are already available, SSNMR
affords unique opportunities to test the structural variations in
different contexts, including in native and mimetic membrane
formulations, and to add insight at the level of chemical and
conformational detail that are not typically derived from ∼2 Å
crystal structures, including states of protonation and hybridiza-
tion, hydrogen bonding, and functionally relevant dynamic
events.
2. Materials and methods
2.1. Chemicals and reagents
Luria Broth (LB), Terrific Broth (TB) and M9 salts were made according to
Sambrook et al. [43]. The recipe for 1 L of supplemented minimal growth media
is shown in Table 1. Ampicillin, chloramphenicol, tetracycline, L-arabinose, δ-
aminolevulinic acid (ALA) and other chemicals were obtained from Sigma
Chemical (St. Louis, MO). Natural abundance and isotopically (13C,15N)
enriched Bioexpress-1000, 15NH4Cl and uniformly labeled
13C-D-glucose were
Table 1
Supplemented minimal growth media
Minimal growth media (1 L)
10× M9 salts 100 mL
20% D-glucose 20 mL
Bioexpress 1000 10 mL
1 M MgCl2 2 mL
1 M CaCl2 0.1 mL
10× M9 salts
KH2PO4 30.0 g
Na2HPO4d 7H2O 128.0 g
NaCl 5.0 g
NH4Cl (pH adjusted to 7.2 with NaOH) 10.0 g
At the time of induction, δ-aminolevulinic acid is added to a final concentration
of 0.5 mM. For isotopic labeling, 15NH4Cl and
13
D-glucose and 13C,15N
isotopically-enriched Bioexpress 1000 were substituted for unlabelled NH4Cl
and D-glucose.
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expression vector was purchased from Novagen (Darmstadt, Germany) and the
molecular chaperone expression plasmids pGro7 and pGKJE8 were purchased
from Fisher Scientific (Hampton, NH). Ni-NTA resin was purchased from
Qiagen (Valencia, CA) and CM-Sepharose (fast flow) was purchased from
Amersham Biolabs (Piscataway, NJ).
2.2. Construction and modification of CYP98A3 expression plasmid
The CYP98A3 cDNA [14] was cloned into the IPTG-inducible pET28a
(Novagen, San Diego, CA) and pCWori [44] expression vectors between the
NcoI–HindIII and NdeI–XbaI restriction sites, respectively, using PCR-based
strategies. For optimal expression in E. coli, the 5′ primer directed against the
translation start contained the initial methionine codon, an inserted alanine codon
(residue 2) and E. coli optimized codons for the residues 2–11 in the wildtype
CYP98A3 (renumbered residues 3–12 in the engineered CYP98A3). For
purification purposes, the 3′ primer contained four histidine codons (His4-tag)
downstream from the C-terminal amino acid. The 5′ primer sequence for the
pET28a vector corresponds to 5′-cgtctcacatgtcttggtttctgattgcggtggcgactatcgc-3′
(translation start is underlined) and the 3′ primer sequence for the pET28a vector
corresponds to 5′-cgagaagcttaatgatgatgatgcatatcg-3′ (translation stop is double
underlined). The 5′ primer sequence for the pCWori vector corresponds to 5′-
aagggaattccatatgtcttggtttctgattgcggtggcgactatcgc-3′ and the 3′ primer sequence
for the pCWori vector corresponds to 5′-ctgctctagattaatgatgatgatgcatatcgtaagg-
cacgcggt-3′.
2.3. Expression conditions for CYP98A3
Expressions with the pET28a vector were performed in the E. coli BL21
strain and with the pCWori vector were performed in the E. coli DH5α strain.
Expressions of His4CYP98A3 with the pCWori vector in BL21 (DE3) and XL-
Blue cells (both from Invitrogen) in rich media yielded lower P450 levels than
obtained in DH5α cells.
Expressions in complete TBmedia were performed by inoculating 10mL of a
fresh overnight bacterial culture grown in TB containing 50 mg/L ampicillin into
1000mL of TB (also containing ampicillin) in a 2.5 L Fernbach flask. The culture
was incubated at 37 °Cwith shaking at 200 rpm in a NewBrunswick G-25 orbital
shaker. When the OD600 of the culture reached 0.8, expression was induced by
adding isopropyl-β-D-thiogalactopyranoside (IPTG) to a final concentration of
1 mM. The heme precursor δ-aminolevulinic (ALA) was also added to a final
concentration of 0.5 mM. The rate of shaking was then reduced to 180 rpm and
the temperature was lowered to 28 °C. After an additional 24 h of incubation, the
cells were harvested by centrifuging at 3000×g for 10 min at 4 °C. When the
GroES-GroEL chaperones were co-expressed, the media was supplemented with
an additional 20 mg/L of chloramphenicol for selection/retention of the
chaperone plasmids. Chaperone expression was induced at the same time asP450 expression by adding 4 g/L of L-arabinose for the pGro7 plasmid or 5 μg/L
of tetracycline for the pGKJE8 plasmid.
Expressions in M9 labeling media were performed by inoculating 10 mL of a
fresh overnight bacterial culture grown in LB containing 50 mg/L ampicillin into
1000mL of LB (containing ampicillin) in a 2.5 L Fernbach flask. The culture was
incubated at 37 °C with shaking at 200 rpm in a New Brunswick G-25 orbital
shaker. When the OD600 reached 0.7, cells were pelleted by centrifuging for
30 min at 5000×g. The cell pellets were then washed once with 250 mL of M9
salts solution and repelleted as above. The cells were then gently resuspended in a
volume of M9 minimal media equivalent to one fourth of the original LB culture
volume as originally described by Marley et al. [40] and allowed to recover for
1 h at 28 °C with shaking at 180 rpm. Induction was then carried out with the
conditions described above for induction in complete TB media. Cells were
harvested after an additional 24 h growth at 28 °C. When chaperones were co-
expressed, an additional 20 mg/L chloramphenicol and either 4 g/L arabinose or
5 μg tetracycline were included in the media and expressionwas performed using
the same conditions described above.
2.4. P450 extraction and purification
Cell lysis, protein extraction and purifications were carried out with slight
modifications on the procedures described in Wester et al. [31]. In brief, the cells
were harvested by centrifugation at 3000×g for 10 min at 4 °C. The cells were
then resuspended in 10% of the original culture volume using 20 mM
potassium phosphate buffer (pH 7.4) containing 20% glycerol, 1 mM
phenylmethylsulfonyl fluoride (PMSF) and 10 mM β-mercaptoethanol. The
cell suspension was then treated with 0.3 mg/mL lysozyme for 45 min with
stirring at 4 °C. After 45 min, an equal volume of ice cold water was added
slowly and incubated for an additional 15 min. The spheroplasts were then
pelleted by centrifugation at 5000×g for 10 min at 4 °C and lysed by freezing
in a liquid nitrogen bath. The frozen pellet was thawed on ice and resuspended
in 20% of the original culture volume using lysis/equilibration buffer [500 mM
potassium phosphate buffer (pH 7.4) containing 20% glycerol, 0.5 mM PMSF,
10 mM β-mercaptoethanol, 1% CHAPS]. The spheroplasts were disrupted by
sonicating for three 45 s pulses with 60 s of cooling on ice in between. The
lysate was then centrifuged at 7000×g for 10 min and the supernatant was
centrifuged at 105,000×g for 90 min.
The resulting 200 mL supernatant was directly applied to a 2–3 mLNi-NTA
agarose affinity column (Qiagen) that had been pre-equilibrated with the lysis/
equilibration buffer. After applying the cell lysate, the resin was washed with five
volumes of the lysis/equilibration buffer and two volumes of wash buffer
[100 mM potassium phosphate buffer (pH 7.4) containing 100 mM NaCl, 20%
glycerol, 1 mM PMSF, 10 mM β-mercaptoethanol]. The column was
subsequently washed with five column volumes of wash buffer containing
50 mM glycine and then another five column volumes of wash buffer containing
10 mM histidine. And, finally the P450 was eluted with 10 mM potassium
phosphate buffer (pH 7.4) containing 100mMNaCl, 20% glycerol, 1 mMPMSF,
10 mM β-mercaptoethanol, 1% CHAPS, and 40 mM histidine.
This eluent was diluted 10-fold with 5 mM potassium phosphate buffer (pH
7.4) containing 20% glycerol, 1 mM PMSF, 1 mM ethylenedinitrilotetraacetic
acid (EDTA), 0.2 mM DL-dithiothreitol (DTT) and 1% CHAPS and applied to a
30-mL CM-Sepharose ion exchange column (Amersham Biosciences, Piscat-
away, NJ). Prior to applying the sample, the resin was equilibrated with five
resin volumes of 10 mM potassium phosphate buffer (pH 7.4) containing 20%
glycerol, 1 mM PMSF, 1 mM EDTA, 0.2 mM DTT and 1% CHAPS. The CM-
Sepharose resin was then washed with five volumes of the equilibration buffer
omitting the CHAPS detergent. The P450 was eluted using 50 mM potassium
phosphate buffer (pH 7.4) with 500 mM sodium chloride, 20% glycerol, 1 mM
EDTA and 0.2 mM DTT.
2.5. Precipitation for SSNMR
For precipitation trials, the fractions from the CM-Sepharose ion exchange
column containing P450 were pooled and concentrated using Centricon-30
concentrators (Millipore Billerica, MA) to 20mg/mL P450, as assayed by carbon
monoxide (CO) difference spectra [45]. This concentrated protein sample was
used to examine a small range of precipitation conditions based on the
crystallographic screening of CYP98A3 (S.G. Rupasinghe, M.A. Schuler and C.
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Biorad Protein Assay kit (Hercules, CA).
Dialysis in 0.1 M cacodylate (pH 6.5), 0.2 M MgCl2, 20% PEG-1000 buffer
for 48 h resulted in a non-amorphous precipitant. Purified His4CYP98A3
expressed in labeling media was precipitated using the above conditions and was
compacted using ultracentrifugation at 100,000×g for 45 min in a Beckman TL-
100 ultracentrifuge. The dense-packed brown pellet was transferred to a 3.2-mm
standard diameter rotor (Varian, Palo Alto, CA) and rubber discs were placed at
each end of the rotor to prevent sample dehydration.
2.6. SSNMR spectroscopy
SSNMR 1D and 13C–13C 2D DARR mixing spectra were acquired at 17.6 T
on a Varian Unity Inova console, using a triple resonance (1H–13C–15N) Bio-
MAS probe (Varian Inc., Palo Alto, CA) [46] with an magic-angle spinning
(MAS) rate of 12.50 kHz. 13C 1D and 13C–13C 2D DARR mixing spectra were
acquired with a 0.7 ms 1H to 13C cross polarization (CP) contact time using a
tangent ramp on 1H [47] and an acquisition time of 41 ms, with 88 kHz of TPPM
decoupling [48]. The 13C–13C spectrumwas acquiredwith 1024 rows and a 20 μs
dwell time (States hypercomplex sampling) [49] in the indirect dimension
utilizing 10 ms of DARRmixing [50]. The 15N spectrum had an acquisition time
of 41 ms with 2 ms CP using a tangent ramp on 1H and 95 kHz of TPPM
decoupling. Total signal averaging timeswere 15min (1024 scans) for the 13C 1D
and 30 min (2048 scans) for the 15N 1D spectra and 98 h (156 scans) for the
2D 13C–13C spectrum. All data were acquired at −50 °C (nominal temperature
measured at the output of the variable temperature stack) using 95 scfh variable
temperature flow. Data acquired at 17.6 T utilized the low E-field BioMAS
probe to reduce RF-induced sample heating. The actual sample temperature
is 5–10 °C higher due to frictional heating from spinning [46].
The 13C–13C INADEQUATE spectrum was acquired at 11.7 T on a Varian
Infinity Plus console, using a 3.2-mm Balun probe (Varian Inc., Palo Alto, CA)
customized for 1H, 13C and 15N triple resonance experiments. The MAS rate was
11.11 kHz. The direct dimension acquisition time was 23 ms, following a 0.9 ms
tangent ramped 1H to 13C CP, one supercycle of SPC-53 mixing (0.54 ms) each
for excitation and reconversion of double-quantum coherence. During themixing
period,∼110 kHz continuous wave decoupling was employed; during evolution
and acquisition, 70 kHz TPPM decoupling was employed. The indirect (double-
quantum) 13C dimension was digitized to 768 rows with a 15 μs dwell time (time
proportional phase incrementation (TPPI) sampling) [51]. The 2D spectrum was
signal averaged for 145 h at −50 °C (nominal temperature) using 90 scfh variable
temperature flow. The actual sample temperature is 15–25 °C higher due to
frictional heating from spinning and dielectric heating from the RF pulses
[46,52].3. Results
The pCWori vector that contains the IPTG-inducible tac
promoter has been used to successfully express a number of
N-terminally truncated P450s at high yields in E. coli [31]. In
complete TB media, our initial expressions of Arabidopsis
CYP98A3 using this pCWori vector yielded 3 mg P450
protein per liter of culture media as defined by CO difference
analysis (Table 2). But, in M9 minimal media, this sameTable 2
CYP98A3 expression
Promoter/chaperone
co-expression system
P450 yield (mg/L)
M9 minimal media Terrific broth
tac promoter/no chaperones nd 3
T7 promoter/no chaperones nd 3
tac promoter/araB groES-groEL 4 8
tac promoter/pzt1 groES-groEL 2 6construct failed to yield any detectable P450 in spite of the
fact that the N-terminal codons had been optimized for E.
coli. Use of the pET28a vector that contains the IPTG-
inducible bacteriophage T7 promoter has been used success-
fully to express soluble Synechocystis CYP120 in E. coli for
structural analysis [53]. As for the pCWori construct,
expression of full-length His4CYP98A3 in the pET28a vector
produced high yields of P450 in complete media and no
detectable P450 in M9 minimal media.
Since it had been shown that human CYP8A1 (prostaglandin
synthase) and CYP3A7 protein expressions were elevated when
co-expressed with molecular chaperones GroEL and GroES
[54,55], His4CYP98A3 was expressed in the presence of these
molecular chaperones under control of the arabinose-inducible
araB promoter (pGro7 plasmid). With these co-expressed pro-
teins, CYP98A3 expression driven by the tac promoter was sig-
nificantly elevated in complete media (Table 2) and detectable
for the first time in M9 minimal media. Using these plasmids,
expression and arabinose induction conditions, the yield of
His4CYP98A3 in minimal media was 4 mg/L.
Since it is possible that the arabinose used for induction with
ara+ strains could enter central metabolism thereby diluting
isotope pools [56], expression was also attempted with
molecular chaperones under control of the tetracycline-
inducible pzt-1 promoter. CYP98A3 expression in this co-
expression system occurred at a slightly lower level in complete
media than with the araB promoter system and at half the level
obtained in minimal media (Table 2). Nevertheless, this system
yielded 4 mg of 13C,15N-labeled His4CYP98A3, as determined
by CO difference analysis of the crude cell lysate, from 2 L
of isotopically-enriched minimal media. Purification of this
sample as described in Materials and methods yielded
CM-Sepaharose ion exchange fractions that were approximate-
ly 90% clean after pooling (and before concentrating) (Fig. 1).
The CO-bound difference spectrum displayed a single peak at
450 nm indicating that the purified protein was appropriately
folded and stable (Fig. 1b). These fractions were pooled,
concentrated to 20 mg/mL and precipitated using conditions
determined for precipitating unlabeled CYP98A3. A smaller
13C,15N-labeled His4CYP98A3 sample precipitated under the
same conditions generated an absorption peak at 450 nm with a
small shoulder at 420 nm (Fig. 1c) when redissolved and
analyzed by CO-difference spectroscopy, indicating that the
labeled protein does not unfold upon precipitation.
SSNMR analysis of His4CYP98A3 yielded spectra consis-
tent with a uniformly 13C,15N-labeled, folded and homogenous
protein. The 13C and 15N CP-MAS spectra (Fig. 2) have
integrated signal intensities consistent with 2.5–3.0 mg of
13C,15N-labeled protein (based on instrument calibrations
performed with standard proteins of known quantity [57]).
Integration of the 13C CP-MAS spectrum (Table 3) by region
reports signal patterns consistent with the expected number of
signals in each spectral region. For example, aliphatic 13C
signals with directly-bonded protons (including Cα, Cβ and
methyls) have a CP enhancement factor of about two, indicating
that the sample is predominantly rigid along the protein
backbone. Non-protonated 13C sites have lower CP enhance-
Fig. 1. SDS-PAGE gel electrophoresis and CO-difference analysis of 13C,15N-labeled His4CYP98A3. (a) lane 1, NTA-bound
13C,15N-labeled His4CYP98A3
(58.3 kDa for natural abundance protein and 61.6 kDa for fully 13C,15N-labeled protein); lane 2, ion exchange-bound 13C,15N-labeled His4CYP98A3; lane 3, protein
standards of 21.4, 29.0, 36.2, 51.2, 90.0 and 110 kDa. (b) CO difference analysis of concentrated 13C,15N-labeled His4CYP98A3 protein. (c) CO difference analysis of
the redissolved 13C,15N-labeled His4CYP98A3 precipitate.
3065S.G. Rupasinghe et al. / Biochimica et Biophysica Acta 1768 (2007) 3061–3070ment. The dispersion of aliphatic and carbonyl resonances is
consistent with expectations for a folded protein, as discussed
further in the context of the 2D experiments below. The 1D 15N
spectrum shows no individually resolved signals, as expected for
a protein of this size. However, the amide chemical shift
dispersion from ∼100 to ∼140 ppm arises from amino acid
types in distinct secondary structures, indicative of a folded
protein.
Characteristic resonances of individual amino acids in the
protein are resolved in 2D spectra. For example, significant
dispersion of chemical shifts in the 13C–13C correlation
spectrum is derived from secondary shifts of Cα and Cβ sites,
as well as conformation-dependent chemical shifts of side-chain
resonances (Fig. 3). The majority of the peak intensity reports α-
helical Cα, Cβ and C' (backbone carbonyl) chemical shifts [58].
Smaller portions of the signals have shifts consistent with β-
sheet or turn secondary structure. In addition to providing
secondary structure information, the 13C–13C spectrum has, inFig. 2. SSNMR 1D spectra of CYP98A3. (a) 13C CP-MAS spectrum of uniformly 13C
shown with 30 Hz Lorenzian-to-Gaussian line broadening applied. (b) 15N CP-MAS
line broadening applied.the well-resolved regions of the spectrum, the expected number
signals for a single structural conformation of His4CYP98A3.
Illustrative of this, the region from 15 to 25 ppm in F1 and 170 to
185 in F2 includes only Ala Cβ–C' signals at the 10 ms mixing
time used (Fig. 3b). The polarization transfer dynamics under
this condition of spinning and with the particular pulse sequence
used on this instrument were calibrated with several model
proteins, such as GB1. [57] Peak counts performed manually or
by Sparky [59] yielded 35 signals in this region, close to the
number of Ala residues (42) in His4CYP98A3. Likewise, peak
counts of the Gly C'–Cα region of the spectrum (Fig. 3c) yield
25 signals, in good agreement with the 28 Gly residues in the
protein. The Ile Cγ1–Cδ region (Fig. 3d) showed 22 resolved
resonances of the 26 Ile expected from the CYP98A3 sequence.
In some instances, signals are partially overlapped, but can
readily be distinguished with standard methods. The agreement
with the expected number of signals is not perfect because signal
intensities may vary due to local side-chain dynamics and/or,15N-labeled His4CYP98A3. This spectrum was acquired for 1024 scans and is
spectrum acquired for 2048 scans is shown with 40 Hz Lorenzian-to-Gaussian
Table 3
Integrated intensities of 13C CP-MAS spectrum of 13C,15N-labeled CYP98A3
Signal
type
Integrated
area
Cross polarization
(CP) intensity
Number of
expected signals
Intensity/number Direct polarization
(DP) intensity
Relative CP
signal intensity(%) a
Carbonyl 166–192 ppm 803 602 1.33 540 148
Tyr/Arg Cf 152–164 pm 48 53 0.91 30 159
Aromatic 102–145 ppm 363 337 1.08 370 98
Cα 48.5–78 ppm 1148 561 2.05 545 204
Cβ 24.5–48.5 ppm 1423 701 2.03 788 181
Methyl 10–24.5 ppm 628 309 2.03 300 209
a CP intensity divided by DP intensity.
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line widths in general are 0.5 ppm or less, consistent with factors
such as scalar 13C–13C couplings contributing a major part of
the observed line width.
In addition to the residue types most easily identified in the
broadband 13C–13C single quantum correlation spectrum (Gly,
Ala, Ile), the Ser and Thr residues appear in unique regions of the
spectrum, near the diagonal with downfield shifted Cβ signals.
Ser and Thr residues in helical conformations have similar Cα
and Cβ chemical shifts and, therefore, may be hard toFig. 3. 13C–13C spectrum of CYP98A3 with 10 ms DARR mixing. (a) Aliphatic a
carbonyl region displays methyls and methylenes correlated to their backbone carbony
(d) The ileleucine Cγ1–Cδ region of the spectrum shows 22 resolved correlations. T
dimensions, respectively. Data were acquired for 98 h, utilizing a 1-s pulse delay.distinguish from the diagonal intensity. To partially remedy
this situation we performed a 2D 13C–13C INADEQUATE
correlation experiment (Fig. 4). The spectrum avoids auto-
correlated peaks by virtue of a double-quantum filter and the
selected double-quantum excitation and reconversion time
(using SPC-5) [60] ensures that only one-bond correlations
appear with significant intensity. These features make the
spectrum ideal to view the near diagonal α-helical Ser and Thr
Cα–Cβ correlations (Fig. 4a) and ascertain the distribution of
secondary structure. Likewise, the INADEQUATE spectrumnd carbonyl regions of the His4CYP98A3 spectrum. (b) The expansion of the
l. (c) The glycine C′–Cα region of the spectrum shows 25 resolved correlations.
he spectrum is shown with 47 Hz and 67 Hz of line broadening in the F2 and F1
3067S.G. Rupasinghe et al. / Biochimica et Biophysica Acta 1768 (2007) 3061–3070amplifies the dispersion of Gly C'–Cα correlations that have a
large dispersion among secondary structure elements (Fig. 4b),
many of which are uniquely resolved even at the relatively low
spectrometer frequency of 500 MHz. This is due to the Cα and
C' chemical shifts both increasing when the residue in anα-helix
and decreasing when found in a β-sheet structure. This
difference is magnified in the F1 dimension where the ω1 and
ω2 frequencies are added. Integration of the Gly C'–Ca regions
shows that 57% of the Gly residues are in α-helices, 31% in a
turn conformation and 12% of the Gly in β-sheets.Fig. 4. 13C–13C INADEQUATE spectrum of CYP98A3. (a) The full His4CYP98A3 s
Asp Cβ–Cγ and Glu Cγ–Cδ correlations are very resolved in this spectrum. Seconda
spectrum was processed with 35 Hz (F2) and 40 Hz (F1) of Lorenzian-to-Gaussian4. Discussion
We have developed improved protocols for expression and
purification of isotopically labeled P450 monooxygenases,
enabling preparation of uniformly 13C,15N-labeled samples in
sufficient quantities to perform 2D MAS SSNMR experiments.
Expression conditions were optimized based upon co-expres-
sion of chaperones, adjustment of incubation temperature and
aeration parameters, and formulation of media according
protocols by Marley et al. [40]. His4CYP98A3 was preparedpectrum with the Ser and Thr Cα–Cβ correlations enlarged. (b) The Gly C′–Cα,
ry structure information can be easily observed in the expansion on the right. The
line broadening applied. Datum were acquired for 145 h with a 3-s pulse delay.
3068 S.G. Rupasinghe et al. / Biochimica et Biophysica Acta 1768 (2007) 3061–3070in sufficiently high purity with CO binding assays demonstrating
that the majority of the material was in the appropriately folded
form. Precipitation of the protein by low molecular weight PEG
yielded essentially quantitative yields of microscopically well-
ordered samples for SSNMR.
SSNMR2Dchemical shift correlation spectra of His4CYP98A3
show that the protein is folded in a single structural
conformation, based upon observations of approximately the
correct number of Gly, Ala and Ile spin systems. Although
some signals may have depressed intensities and, therefore, be
under the threshold for detection in these spectra, the majority
of sites are observed. Signal intensities and enhancement factors
by CP are in agreement with other proteins (microcrystalline,
membrane or fibrous) studied in our laboratories. Thus the
sample is microscopically well ordered, with linewidths of
approximately 0.5 ppm, and shows all evidence of a folded
tertiary structure, based upon biophysical characterization,
optical spectroscopic signatures, as well as SSNMR spectros-
copy. Over 3–4 weeks of NMR acquisition, the sample retained
its native structure as evidenced by the unchanged 13C-CP 1D
appearance.
In this analysis, His4CYP98A3 is a full-length membrane
protein (58.3 kDa in its native form) prepared as a macroscopic
precipitate by PEG precipitation, a method similar to the
manner in which crystals of truncated, soluble forms of
eukaryotic P450s are often prepared for crystallographic
studies. Consequently, the SSNMR spectra of this full-length
protein can be compared directly to crystallographic studies of
mammalian P450 monooxygenases lacking only their N-
terminal signal anchor sequence. Since single crystals are not
required for SSNMR, a significantly larger range of conditions
and substrate-bound forms can be examined. Additionally, the
incorporation of CYP98A3 into nanoscale discoidal lipid
bilayers (Nanodiscs) [61–64] can enable studies of the
conformational effects of substrate binding and/or varying
associations with lipid bilayers.
Despite the large size of this protein, the fact that the 2D
spectra have sufficient sensitivity and resolution with only a
few days of acquisition demonstrates that SSNMR has the
potential to provide structural and mechanistic information for
P450 monooxygenases that may not be amenable to crystal-
lographic study or correctly folded under conditions suitable
for single crystal growth. To perform complete chemical shift
assignments and determine de novo structures from the
SSNMR spectra alone will require application of more time-
consuming 3D experiments. With the samples as prepared,
such 3D experiments would require approximately 7 to 10 day
acquisition times. The development of high-yield expression
protocols now enables larger quantities of materials to be
prepared for this analysis. This capability, in combination with
advances in SSNMR methodology, promises to permit more
complete analyses of structural data in this important class of
membrane-associated proteins. Thus, the current study repre-
sents an important advance, enabling the preparation of large
quantities of isotopically labeled P450 monooxygenases, which
will be applicable to a range of similar proteins for SSNMR
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